The Royal Victoria Infirmary is a 673-bed tertiary referral centre in Newcastle upon Tyne, England. The hospital is part of the Newcastle upon Tyne Hospitals NHS Foundation Trust and is a teaching hospital for the University of Newcastle upon Tyne.

There are 620 beds in Newcastle Hemophilia Comprehensive Care Centre.

During the past decade, Newcastle Hemophilia Comprehensive Care Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Newcastle Hemophilia Comprehensive Care Centre" are "Hemophilia B" (2 trials), "Blood Coagulation Disorder" (1 trials), "Blood Coagulation Disorders, Inherited" (1 trials) and "Haematologic Disease" (1 trials). Many other conditions were trialed in "Newcastle Hemophilia Comprehensive Care Centre" in a lesser frequency.

Most popular intervention types in "Newcastle Hemophilia Comprehensive Care Centre" are "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "FLT180a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Newcastle Hemophilia Comprehensive Care Centre" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Newcastle Hemophilia Comprehensive Care Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Newcastle Hemophilia Comprehensive Care Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Newcastle Hemophilia Comprehensive Care Centre, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".